SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-035030
Filing Date
2024-03-15
Accepted
2024-03-15 16:33:46
Documents
6
Effectiveness Date
2024-03-15

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm248258d1_s8.htm S-8 38374
2 EXHIBIT 5.1 tm248258d1_ex5-1.htm EX-5.1 9887
3 EXHIBIT 23.1 tm248258d1_ex23-1.htm EX-23.1 2344
4 EX-FILING FEES tm248258d1_exfilingfees.htm EX-FILING FEES 12550
5 GRAPHIC tm248258d1_ex5-1img001.jpg GRAPHIC 7395
6 GRAPHIC tm248258d1_ex5-1img002.jpg GRAPHIC 1584
  Complete submission text file 0001104659-24-035030.txt   76979
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277994 | Film No.: 24755357
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)